Initial Statement of Beneficial Ownership (3)
28 May 2020 - 9:53AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Ferenczy William J. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/18/2020
|
3. Issuer Name and Ticker or Trading Symbol
QUIDEL CORP /DE/ [QDEL]
|
(Last)
(First)
(Middle)
9975 SUMMERS RIDGE ROAD |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) SVP, Cardio/Metabolic Unit / |
(Street)
SAN DIEGO, CA 92121
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 4390 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-Qualified Stock Options (Right to Buy) | (1) | 2/5/2025 | Common Stock | 1954 | $23.41 | D | |
Non-Qualified Stock Options (Right to Buy) | (2) | 2/10/2026 | Common Stock | 3910 | $15.40 | D | |
Non-Qualified Stock Options (Right to Buy) | (3) | 2/15/2027 | Common Stock | 1349 | $21.08 | D | |
Non-Qualified Stock Options (Right to Buy) | (4) | 1/16/2028 | Common Stock | 1727 | $46.41 | D | |
Non-Qualified Stock Options (Right to Buy) | (5) | 2/4/2029 | Common Stock | 3322 | $59.12 | D | |
Non-Qualified Stock Options (Right to Buy) | (6) | 2/3/2030 | Common Stock | 2609 | $77.16 | D | |
Non-Qualified Stock Options (Right to Buy) | (7) | 3/30/2030 | Common Stock | 1737 | $103.64 | D | |
Restricted Stock Units | 2/15/2021 | 2/15/2021 | Common Stock | 675 | $0.00 (8) | D | |
Restricted Stock Units | 6/12/2021 | 6/12/2021 | Common Stock | 2000 | $0.00 (8) | D | |
Restricted Stock Units | 1/16/2022 | 1/16/2022 | Common Stock | 1727 | $0.00 (8) | D | |
Restricted Stock Units | 2/4/2023 | 2/4/2023 | Common Stock | 1661 | $0.00 (8) | D | |
Restricted Stock Units | (9) | (9) | Common Stock | 2609 | $0.00 (8) | D | |
Restricted Stock Units | (10) | (10) | Common Stock | 1736 | $0.00 (8) | D | |
Explanation of Responses: |
(1) | 977 shares vested on 02/05/2018 and 977 shares vested on 02/05/2019. |
(2) | 1,956 shares vested on 02/10/2018; 977 shares vested on 02/10/2019; and 977 shares vested on 02/10/2020. |
(3) | 675 shares vested on 02/15/2019; 337 shares vested on 02/15/2020; and 337 shares will vest on 02/15/2021. |
(4) | 864 shares will vest on 01/16/2021 and 863 shares will vest on 01/16/2022. |
(5) | 1,662 shares will vest on 02/04/2021; 830 shares will vest on 02/04/2022; and 830 shares will vest on 02/04/2023. |
(6) | 653 shares will vest on 02/03/2021; 652 shares will vest on 02/03/2022; 652 shares will vest on 02/03/2023; and 652 shares will vest on 02/03/2024. |
(7) | 435 shares will vest on 03/30/2021; 434 shares will vest on 03/30/2022; 434 shares will vest on 03/30/3023; and 434 shares will vest on 03/30/2024. |
(8) | Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. |
(9) | 653 shares will vest on 02/03/2021; 652 shares will vest on 02/03/2022; 652 shares will vest on 02/03/2023; and 652 shares will vest on 02/03/2024. |
(10) | 434 shares will vest on 03/30/2021; 434 shares will vest on 03/30/2022; 434 shares will vest on 03/30/2023; and 434 shares will vest on 03/30/2024. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Ferenczy William J. 9975 SUMMERS RIDGE ROAD SAN DIEGO, CA 92121 |
|
| SVP, Cardio/Metabolic Unit |
|
Signatures
|
Robert J. Bujarski, attorney-in-fact for William J. Ferenczy | | 5/27/2020 |
**Signature of Reporting Person | Date |
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Apr 2024 to May 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2023 to May 2024